Establishment of an X-ray irradiation-induced glossitis model in rats: Biphasic elevation of proinflammatory cytokines and Chemokines

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 3, 2013, Pages 660-668

  Nakashima, Takako ^a,b   Uematsu, Naoya ^a,b   Shibamori, Masafumi ^a,b   Sakurai, Kazushi ^a,b   Ishida, Tatsuhiro ^a  

^a Institute of Health Biosciences   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PALIFERMIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; GLOSSITIS; HISTOPATHOLOGY; INFLAMMATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RAT; X IRRADIATION;

ANIMALS; CHEMOKINES; CYTOKINES; FIBROBLAST GROWTH FACTOR 7; GENE EXPRESSION; GLOSSITIS; MALE; MUCOSITIS; RADIATION INJURIES, EXPERIMENTAL; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; TONGUE; X-RAYS;

EID: 84887975816     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.208405     Document Type: Article

References (34)

1. Ara G, Watkins BA, Zhong H, Hawthorne T.R., Karkaria CE, Sonis ST, and Larochelle WJ (2008) Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation. Int J Radiat Biol 84: 401-412. (Pubitemid 351878838)
2. Blazar BR, Weisdorf DJ, Defor T, Goldman A., Braun T, Silver S, and Ferrara JL (2006) Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). Blood 108:3216-3222.
3. Borges L, Rex KL, Chen J.N., Wei P., Kaufman S, Scully S, Pretorius J.K., and Farrell CL (2006) A protective role for keratinocyte growth factor in a murine model of chemotherapy and radiotherapy-induced mucositis. Int J Radiat Oncol Biol Phys 66:254-262. (Pubitemid 44175675)
4. Bowen JM, Gibson RJ, and Keefe DM (2011) Animal models of mucositis: implications for therapy. J Support Oncol 9:161-168.
5. Cassatt DR, Fazenbaker CA, Bachy C.M., and Hanson MS (2002) Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy. Semin Radiat Oncol 12(1, Suppl 1)97-102. (Pubitemid 34246077)
6. Cassatt DR, Fazenbaker CA, Kifle G, and Bachy CM (2003) Subcutaneous administration of amifostine (ethyol) is equivalent to intravenous administration in a rat mucositis model. Int J Radiat Oncol Biol Phys 57:794-802. (Pubitemid 37194307)
7. Dörr W., Brankovic K, and Hartmann B (2000) Repopulation in mouse oral mucosa: changes in the effect of dose fractionation. Int J Radiat Biol 76:383-390. (Pubitemid 30137745)
8. Dörr W., Spekl K, and Martin M (2002) Radiation-induced oral mucositis in mice: strain differences. Cell Prolif 35 (Suppl 1):60-67. (Pubitemid 34985148)
9. Dörr W., Bässler S, Reichel S., and Spekl K (2005a) Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice. Int J Radiat Oncol Biol Phys 62: 881-887. (Pubitemid 40779782)
10. Dörr W., Heider K, and Spekl K (2005b) Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF. Int J Radiat Biol 81:557-565. (Pubitemid 41784877)
11. Farrell CL, Rex KL, Kaufman S.A., Dipalma CR, Chen JN, Scully S, and Lacey DL (1999) Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int J Radiat Biol 75: 609-620. (Pubitemid 29243139)
12. Fleischer G and Dörr W (2006) Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine. Strah-lenther Onkol 182:567-575. (Pubitemid 44484268)
13. Gibson RJ, Bowen JM, and Keefe DM (2005) Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats. Int J Cancer 116:464-470. (Pubitemid 40993345)
14. Henke M, Alfonsi M, Foa P., Giralt J, Bardet E, Cerezo L., Salzwimmer M, Lizambri R, Emmerson L., and Chen MG, et al. (2011) Palifermin decreases severe oral muco-sitis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 29:2815-2820.
15. Jaal J, Richter C, and Dörr W (2010) Effect of recombinant human keratinocyte growth factor (Δ23rHuKGF, Palifermin) on inflammatory and immune changes in mouse tongue during fractionated irradiation. Int J Radiat Biol 86: 860-866.
16. Keefe DM, Schubert MM, Elting L.S., Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire D.B., Hutchins RD, and Peterson DE; Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820-831. (Pubitemid 46335677)
17. Kiliç Y, Rajewski K, and Dörr W (2007) Effect of post-exposure administration of keratinocyte growth factor (Palifermin) on radiation effects in oral mucosa in mice. Radiat Environ Biophys 46:13-19. (Pubitemid 46354800)
18. Kitagawa J, Nasu M, Okumura H., Shibata A, Makino K, Terada H., and Matsumoto S (2008) Allopurinol gel mitigates radiation-induced mucositis and dermatitis. J Radiat Res (Tokyo) 49:49-54. (Pubitemid 351214417)
19. Lalla RV, Sonis ST, and Peterson DE (2008) Management of oral mucositis in patients who have cancer. Dent Clin North Am 52:61-77, viii.
20. Le QT, Kim HE, Schneider C.J., Muraközy G, Skladowski K., Reinisch S, Chen Y, Hickey M., Mo M, and Chen MG, et al. (2011) Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 29: 2808-2814.
21. Li CY, Chen XH, Tao X.A., Xia J., and Cheng B (2011) The development and inflammatory features of radiotherapy-induced glossitis in rats. Med Oral Patol Oral Cir Bucal 16:e348-e353.
22. Logan RM, Stringer AM, Bowen J.M., Yeoh AS, Gibson RJ, Sonis ST, and Keefe DM (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33:448-460. (Pubitemid 47324227)
23. Mangoni M, Yue X, Morin C., Violot D, Frascogna V, Tao Y., Opolon P, Castaing M, Auperin A., and Biti G, et al. (2009) Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection. Int J Radiat Oncol Biol Phys 74:1242-1250.
24. Murphy CK, Fey EG, Watkins B.A., Wong V., Rothstein D, and Sonis ST (2008) Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters. Clin Cancer Res 14:4292-4297.
25. Rezvani M and Ross GA (2004) Modification of radiation-induced acute oral mucositis in the rat. Int J Radiat Biol 80:177-182. (Pubitemid 38402440)
26. Ryu SH, Kang KM, Moon S.Y., Chai GY, Hong JP, Cho KO, Kang M.I., Choi EK, and Lee SW (2010) Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis. J Radiat Res (Tokyo) 51:595-601.
27. Sonis ST, Tracey C, Shklar G., Jenson J, and Florine D (1990) An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Pathol 69:437-443. (Pubitemid 20139218)
28. Sonis ST, Costa JW, Jr, Evitts SM, Lindquist LE, and Nicolson M (1992) Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 74:749-755. (Pubitemid 23005444)
29. Sonis ST, Elting LS, Keefe D, Peterson D.E., Schubert M., Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly J.P., and Rubenstein EB; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9, Suppl):1995-2025. (Pubitemid 38528741)
30. Sonis ST (2004) Oral mucositis in cancer therapy. J Support Oncol 2(6, Suppl 3):3-8. (Pubitemid 40100644)
31. Spielberger R, Stiff P, Bensinger W., Gentile T, Weisdorf D, Kewalramani T., Shea T, Yanovich S, Hansen K., and Noga S, et al. (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590-2598. (Pubitemid 39628580)
32. 1 on radiation-induced proliferative inhibition and apoptosis in keratinocytes and healing of radiation-induced skin injury in rats. J Radiat Res (Tokyo) 53:385-394.
33. Vissink A, Jansma J, Spijkervet F.K., Burlage FR, and Coppes RP (2003) Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14:199-212. (Pubitemid 44560804)
34. Yeoh AS, Gibson RJ, Yeoh E.E., Bowen JM, Stringer AM, Giam KA, and Keefe DM (2007) A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Mol Cancer Ther 6:2319-2327. (Pubitemid 47294760)